Lawyers in our Mass Torts Section continue to receive reports from kidney disease patients who have suffered debilitating injuries caused by nephrogenic systemic fibrosis (NSF) due to receiv... Read more
The first bellwether trial case in the gadolinium-based contrast agent MDL is scheduled to begin on the 24th of this month. Gadolinium-based contrast agents are marketed by Bayer (Magnevist)... Read more
We are constantly being asked about what is going on in our firm’s Mass Torts Section. Lawyers in the Section are currently investigating a number of drugs and medical devices, and are... Read more
The U.S. Food and Drug Administration (FDA) recently asked manufacturers of all Gadolinium-based contrast agents to include a new boxed warning on the product label. These contrast agents ar... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.